- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Alcon Launches ILEVRO™ for Treatment of Pain and Inflammation Associated with Cataract Surgery

Posted By Dr. Ari Weitzner On January 31, 2013 @ 5:48 am In Cataract,Products | Comments Disabled

Last week, Alcon announced the launch of ILEVRO™ Suspension (nepafenac ophthalmic suspension 0.3%) as a once-daily treatment option for pain and inflammation associated with cataract surgery.

According to Alcon’s release, in two double masked, randomized clinical trials, ILEVRO™ Suspension demonstrated superior clinical efficacy compared to its vehicle; i.e., patients treated with ILEVRO™ Suspension were less likely to have ocular pain and measurable signs of inflammation (cells and flare) at the end of treatment than those treated with its vehicle.

Click here [1] to read the full release on Alcon’s website.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/006983-alcon-launches-ilevro-for-treatment-of-pain-and-inflammation-associated-with-cataract-surgery/

URLs in this post:

[1] Click here: http://invest.alconinc.com/phoenix.zhtml?c=130946&p=irol-newsArticle&ID=1776058&highlight=

Copyright © 2008 Eye Doc Talk. All rights reserved.